side effects of glp 1 agonists Glucagon-like Receptor-1 for obesity: Weight loss outcomes, tolerability, effects, and risks Managing Side Effects of GLP-1
Description
Those who continued GLP-1 treatment for two or two-and-a-half years before discontinuing for the remainder of the study also gained significant risk reduction (7% and 15%, respectively)
Giorgino, GLP-1 receptor agonists for cardiovascular protection: a matter of time
Ridge T, Moretto T, MacConell L, Pencek R, Han J, Schulteis C, et al
Studies on the perfused rat liver
doi: 10.1007/s10557-025-07670-9, 56
Acute effects of glucagon-like peptide-1, GLP-19-36 amide, and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
